» Articles » PMID: 33187072

Put Some Guts into It: Intestinal Organoid Models to Study Viral Infection

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2020 Nov 14
PMID 33187072
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The knowledge about enteric viral infection has vastly increased over the last eight years due to the development of intestinal organoids and enteroids that suppose a step forward from conventional studies using cell lines. Intestinal organoids and enteroids are three-dimensional (3D) models that closely mimic intestinal cellular heterogeneity and organization. The barrier function within these models has been adapted to facilitate viral studies. In this review, several adaptations (such as organoid-derived two-dimensional (2D) monolayers) and original intestinal 3D models are discussed. The specific advantages and applications, as well as improvements of each model are analyzed and an insight into the possible path for the field is given.

Citing Articles

HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa.

Rader A, Cloherty A, Patel K, Almandawi D, Pajkrt D, Wolthers K PLoS Pathog. 2024; 20(12):e1012714.

PMID: 39729509 PMC: 11676502. DOI: 10.1371/journal.ppat.1012714.


Microfluidic Gastrointestinal Cell Culture Technologies-Improvements in the Past Decade.

Teo A, Ng S, Khoo K, Wong S, Li K Biosensors (Basel). 2024; 14(9).

PMID: 39329824 PMC: 11429516. DOI: 10.3390/bios14090449.


Exploring host-commensal-pathogen dynamics in cell line and organotypic human intestinal epithelial models.

Nanlohy N, Johannesson N, Wijnands L, Arroyo L, Wit J, Den Hartog G iScience. 2024; 27(5):109771.

PMID: 38711444 PMC: 11070716. DOI: 10.1016/j.isci.2024.109771.


MYADM binds human parechovirus 1 and is essential for viral entry.

Qiao W, Richards C, Kim Y, Zengel J, Ding S, Greenberg H Nat Commun. 2024; 15(1):3469.

PMID: 38658526 PMC: 11043367. DOI: 10.1038/s41467-024-47825-0.


Human organoids-on-chips for biomedical research and applications.

Wang H, Ning X, Zhao F, Zhao H, Li D Theranostics. 2024; 14(2):788-818.

PMID: 38169573 PMC: 10758054. DOI: 10.7150/thno.90492.


References
1.
Stanifer M, Kee C, Cortese M, Zumaran C, Triana S, Mukenhirn M . Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Cell Rep. 2020; 32(1):107863. PMC: 7303637. DOI: 10.1016/j.celrep.2020.107863. View

2.
Foulke-Abel J, In J, Kovbasnjuk O, Zachos N, Ettayebi K, Blutt S . Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract. Exp Biol Med (Maywood). 2014; 239(9):1124-34. PMC: 4380516. DOI: 10.1177/1535370214529398. View

3.
Fuller M, Faulk D, Sundaram N, Shroyer N, Henning S, Helmrath M . Intestinal crypts reproducibly expand in culture. J Surg Res. 2012; 178(1):48-54. PMC: 3654833. DOI: 10.1016/j.jss.2012.03.037. View

4.
Straub T, Bentrup K, Orosz-Coghlan P, Dohnalkova A, Mayer B, Bartholomew R . In vitro cell culture infectivity assay for human noroviruses. Emerg Infect Dis. 2007; 13(3):396-403. PMC: 2725917. DOI: 10.3201/eid1303.060549. View

5.
Hakim M, Chen S, Ding S, Yin Y, Ikram A, Ma X . Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids. Sci Rep. 2018; 8(1):8341. PMC: 5974418. DOI: 10.1038/s41598-018-26784-9. View